Tyrese Maxey: Everything you need to know

Tyrese Maxey

Philadelphia 76ers

Status

ACTIVE

STATS

Career Averages

PTS

REB

AST

BLK

STL

21.1

3.2

4.8

0.4

1.1

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	TD3	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	70	70	38.0	28.3	4.1	6.6	0.8	1.9	2.4	7	0	3.1	8.6	36.7%	6.8	12.9	52.5%	9.9	21.4	46.2%	5.3	6.0	89.2%	0.3	3.8	2.2	2.7	+113	58.8%
2024-25	52	52	37.7	26.3	3.3	6.1	0.4	1.8	2.4	8	1	3.1	9.2	33.7%	6.1	11.8	51.5%	9.2	21.0	43.7%	4.9	5.6	87.9%	0.3	3.1	2.2	2.6	-124	56.2%
2023-24	70	70	37.5	25.9	3.7	6.2	0.5	1.0	1.7	9	0	3.0	8.1	37.3%	6.1	12.1	50.1%	9.1	20.3	45.0%	4.7	5.4	86.8%	0.5	3.2	2.2	3.7	+303	57.3%
2022-23	60	41	33.6	20.3	2.9	3.5	0.1	0.8	1.3	0	0	2.7	6.2	43.4%	4.7	9.1	51.3%	7.3	15.2	48.1%	3.0	3.6	84.5%	0.4	2.6	2.2	2.7	+241	60.5%
2021-22	75	74	35.3	17.5	3.2	4.3	0.4	0.7	1.2	1	0	1.8	4.1	42.7%	4.7	9.1	51.2%	6.4	13.3	48.5%	2.8	3.3	86.6%	0.3	2.9	2.1	3.6	+192	59.4%
2020-21	61	8	15.3	8.0	1.7	2.0	0.2	0.4	0.7	0	0	0.5	1.7	30.1%	2.7	5.3	51.2%	3.2	7.0	46.2%	1.0	1.1	87.1%	0.2	1.5	1.3	2.9	-52	53.1%
Career	388	315	33.1	21.1	3.2	4.8	0.4	1.1	1.6	25	1	2.4	6.3	37.7%	5.2	10.1	51.3%	7.5	16.4	46.1%	3.6	4.2	87.3%	0.3	2.9	2.0	3.0	+673	58.0%

Career Averages

PTS

REB

AST

BLK

STL

18.1

3.6

3.4

0.3

0.8

Year	GP	GS	MIN	PTS	REB	AST	BLK	STL	TO	DD2	3PM	3PA	3P%	2PM	2PA	2P%	FGM	FGA	FG%	FTM	FTA	FT%	OREB	DREB	PF	A/TO	+/-	TS%
2025-26	2	2	38.0	25.0	2.5	8.5	0.0	1.0	2.0	0	3.0	8.0	37.5%	6.5	16.0	40.6%	9.5	24.0	39.6%	3.0	3.5	85.7%	0.5	2.0	3.0	4.3	-23	48.9%
2023-24	6	6	44.5	29.8	5.2	6.8	0.3	0.8	2.2	1	3.7	9.2	40.0%	7.3	13.8	53.0%	11.0	23.0	47.8%	4.2	4.7	89.3%	0.2	5.0	2.7	3.2	-8	59.5%
2022-23	11	11	38.5	20.5	4.8	2.3	0.5	1.4	0.7	0	3.1	7.7	40.0%	4.4	9.7	44.9%	7.5	17.5	42.7%	2.5	2.8	90.3%	0.8	4.0	2.4	3.1	+4	55.0%
2021-22	12	12	40.4	20.8	3.5	3.9	0.2	0.8	1.8	0	2.2	5.8	37.7%	5.2	9.4	54.9%	7.3	15.2	48.4%	3.9	4.2	94.0%	0.5	3.0	2.0	2.2	+0	61.0%
2020-21	12	0	13.0	6.3	1.8	1.3	0.5	0.3	0.4	0	0.3	1.0	33.3%	2.1	4.5	46.3%	2.4	5.5	43.9%	1.2	1.8	63.6%	0.1	1.8	1.3	3.2	+11	50.2%
Career	43	31	32.7	18.1	3.6	3.4	0.3	0.8	1.2	1	2.1	5.5	38.8%	4.5	9.0	49.4%	6.6	14.6	45.4%	2.8	3.2	87.0%	0.4	3.1	2.0	2.9	-16	56.8%

Preseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
10/10	ORL	L 128-98	12	17	0	2	0	0	0	6	3	50.0%	8	4	50.0%	14	7	50.0%	0	0	0.0%	0	0	0.0	-2	2	10	60.7%
10/4	NYK	L 113-104	17	16	2	2	0	1	1	7	3	42.9%	3	1	33.3%	10	4	40.0%	6	5	83.3%	1	1	2.0	-6	2	15	63.3%
10/2	NYK	L 99-84	23	14	4	4	1	1	5	4	0	0.0%	8	5	62.5%	12	5	41.7%	4	4	100.0%	0	4	0.8	-5	1	12	50.9%
Preseason Totals			17.6	15.7	2.0	2.7	0.3	0.7	2.0	5.7	2.0	35.3%	6.3	3.3	52.6%	12.0	5.3	44.4%	3.3	3.0	90.0%	0.3	1.7	1.3	-13	1.7	14.3	58.2%

Regular Season
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/10	IND	W 105-94	38	32	8	5	0	2	1	10	1	10.0%	18	10	55.6%	28	11	39.3%	10	9	90.0%	3	5	5.0	+18	3	30	49.4%
4/9	HOU	L 113-102	33	24	3	5	0	0	2	10	5	50.0%	10	4	40.0%	20	9	45.0%	1	1	100.0%	1	2	2.5	-18	3	15	58.7%
4/6	SAS	L 115-102	39	15	3	8	0	0	4	4	1	25.0%	12	5	41.7%	16	6	37.5%	2	2	100.0%	1	2	2.0	-15	2	12	44.4%
4/4	DET	L 116-93	33	23	1	1	0	1	2	5	2	40.0%	12	6	50.0%	17	8	47.1%	7	5	71.4%	1	0	0.5	-27	2	12	57.3%
4/3	MIN	W 115-103	34	21	6	8	2	0	3	3	1	33.3%	10	6	60.0%	13	7	53.8%	6	6	100.0%	0	6	2.7	+14	1	29	67.1%
4/1	WAS	W 153-131	34	28	2	9	0	1	2	5	1	20.0%	15	11	73.3%	20	12	60.0%	4	3	75.0%	0	2	4.5	+28	1	31	64.3%
3/30	MIA	L 119-109	43	23	7	9	2	0	2	9	2	22.2%	11	5	45.5%	20	7	35.0%	7	7	100.0%	0	7	4.5	+1	5	25	49.8%
3/28	CHA	W 118-114	43	26	7	8	1	1	3	6	3	50.0%	12	7	58.3%	18	10	55.6%	4	3	75.0%	0	7	2.7	+13	2	31	65.8%
3/7	ATL	L 125-116	37	31	2	5	0	4	5	7	3	42.9%	15	9	60.0%	22	12	54.5%	4	4	100.0%	0	2	1.0	-10	3	27	65.2%
3/4	UTA	W 106-102	37	25	2	6	3	1	1	10	2	20.0%	12	6	50.0%	22	8	36.4%	7	7	100.0%	0	2	6.0	+8	0	26	49.8%
3/3	SAS	L 131-91	25	21	8	2	1	1	2	6	2	33.3%	13	6	46.2%	19	8	42.1%	4	3	75.0%	0	8	1.0	-36	0	22	50.6%
3/1	BOS	L 114-98	43	33	3	6	2	1	0	11	4	36.4%	23	8	34.8%	34	12	35.3%	6	5	83.3%	1	2	0.0	-9	1	22	45.0%
2/26	MIA	W 124-117	37	28	4	11	1	5	1	12	5	41.7%	14	4	28.6%	26	9	34.6%	5	5	100.0%	0	4	11.0	+6	2	31	49.6%
2/24	IND	W 135-114	33	32	9	8	1	2	2	8	2	25.0%	14	8	57.1%	22	10	45.5%	10	10	100.0%	1	8	4.0	+21	2	41	60.6%
2/22	MIN	W 135-108	35	39	3	8	1	2	5	7	4	57.1%	21	12	57.1%	28	16	57.1%	5	3	60.0%	1	2	1.6	+21	2	32	64.6%
2/21	NOP	L 126-111	36	27	3	7	0	5	5	11	2	18.2%	12	7	58.3%	23	9	39.1%	8	7	87.5%	1	2	1.4	-4	2	23	50.9%
2/19	ATL	L 117-107	38	28	3	3	1	1	2	11	4	36.4%	12	4	33.3%	23	8	34.8%	8	8	100.0%	0	3	1.5	-7	2	19	52.8%
2/11	NYK	L 138-89	32	32	2	2	0	1	1	8	3	37.5%	13	6	46.2%	21	9	42.9%	13	11	84.6%	0	2	2.0	-26	4	25	59.9%
2/9	POR	L 135-118	32	30	1	4	0	1	4	9	2	22.2%	12	8	66.7%	21	10	47.6%	8	8	100.0%	0	1	1.0	-22	4	20	61.2%
2/7	PHX	W 109-103	39	29	9	6	0	1	3	10	3	30.0%	11	5	45.5%	21	8	38.1%	11	10	90.9%	0	9	2.0	+14	2	32	56.1%
2/5	LAL	L 119-115	37	26	0	13	0	4	4	9	1	11.1%	13	10	76.9%	22	11	50.0%	4	3	75.0%	0	0	3.3	+8	5	24	54.7%
2/3	GSW	W 113-94	33	14	4	3	0	2	1	5	1	20.0%	4	2	50.0%	9	3	33.3%	7	7	100.0%	0	4	3.0	+14	1	19	57.9%
2/2	LAC	W 128-113	35	29	5	6	0	3	1	14	7	50.0%	4	2	50.0%	18	9	50.0%	4	4	100.0%	0	5	6.0	+22	4	31	73.4%
1/31	NOP	W 124-114	35	18	5	8	0	1	1	9	4	44.4%	9	3	33.3%	18	7	38.9%	0	0	0.0%	0	5	8.0	+5	3	14	50.0%
1/29	SAC	W 113-111	40	40	4	8	0	1	2	9	4	44.4%	9	8	88.9%	18	12	66.7%	13	12	92.3%	0	4	4.0	+8	3	50	84.3%
1/27	MIL	W 139-122	36	22	3	9	0	0	1	8	2	25.0%	11	7	63.6%	19	9	47.4%	2	2	100.0%	1	2	9.0	+5	2	21	55.3%
1/26	CHA	L 130-93	25	6	2	7	0	0	3	3	0	0.0%	9	3	33.3%	12	3	25.0%	0	0	0.0%	1	1	2.3	-36	0	4	25.0%
1/24	NYK	L 112-109	38	22	3	6	1	2	3	7	3	42.9%	8	5	62.5%	15	8	53.3%	3	3	100.0%	0	3	2.0	-7	4	23	67.4%
1/22	HOU	W 128-122	42	36	2	10	0	3	3	10	2	20.0%	18	13	72.2%	28	15	53.6%	4	4	100.0%	1	1	3.3	+8	1	34	60.5%
1/20	PHX	L 116-110	42	20	2	7	1	3	2	8	2	25.0%	17	5	29.4%	25	7	28.0%	5	4	80.0%	0	2	3.5	+3	3	12	36.8%
1/19	IND	W 113-104	40	29	4	8	1	8	2	4	1	25.0%	20	11	55.0%	24	12	50.0%	4	4	100.0%	1	3	4.0	+16	3	35	56.3%
1/16	CLE	L 117-115	38	22	5	9	2	5	2	8	2	25.0%	15	7	46.7%	23	9	39.1%	2	2	100.0%	1	4	4.5	-4	1	25	46.1%
1/14	CLE	L 133-107	31	14	2	4	2	0	0	8	2	25.0%	8	3	37.5%	16	5	31.3%	2	2	100.0%	0	2	0.0	-22	0	13	41.5%
1/12	TOR	W 115-102	34	33	4	2	0	1	1	9	6	66.7%	7	4	57.1%	16	10	62.5%	7	7	100.0%	1	3	2.0	+13	1	37	86.5%
1/11	TOR	L 116-115	44	38	4	5	2	2	5	7	2	28.6%	20	11	55.0%	27	13	48.1%	12	10	83.3%	0	4	1.0	+17	5	33	58.9%
1/9	ORL	W 103-91	37	29	1	1	0	3	1	8	3	37.5%	14	7	50.0%	22	10	45.5%	6	6	100.0%	0	1	1.0	+7	0	24	58.8%
1/7	WAS	W 131-110	28	22	3	8	1	2	2	10	4	40.0%	5	5	100.0%	15	9	60.0%	1	0	0.0%	0	3	4.0	+20	1	28	71.2%
1/5	DEN	L 125-124	45	28	6	6	2	4	1	9	4	44.4%	13	6	46.2%	22	10	45.5%	6	4	66.7%	0	6	6.0	-1	1	33	56.8%
1/3	NYK	W 130-119	37	36	8	4	2	1	4	9	6	66.7%	13	8	61.5%	22	14	63.6%	4	2	50.0%	0	8	1.0	+6	1	39	75.8%
1/1	DAL	W 123-108	42	34	8	10	2	2	3	10	4	40.0%	14	10	71.4%	24	14	58.3%	2	2	100.0%	0	8	3.3	+18	0	44	68.3%
12/30	MEM	W 139-136	43	34	4	12	0	2	0	7	4	57.1%	14	9	64.3%	21	13	61.9%	5	4	80.0%	1	3	0.0	+2	3	42	73.3%
12/28	OKC	L 129-104	36	28	2	5	0	4	5	7	2	28.6%	11	8	72.7%	18	10	55.6%	7	6	85.7%	0	2	1.0	-22	2	27	66.4%
12/26	CHI	L 109-102	40	27	5	8	2	0	2	11	5	45.5%	13	4	30.8%	24	9	37.5%	4	4	100.0%	0	5	4.0	+0	3	24	52.4%
12/23	BKN	L 114-106	39	13	3	2	0	4	4	5	0	0.0%	9	3	33.3%	14	3	21.4%	7	7	100.0%	0	3	0.5	-19	4	7	38.1%
12/20	DAL	W 121-114	40	38	2	4	1	1	0	11	5	45.5%	20	10	50.0%	31	15	48.4%	3	3	100.0%	0	2	0.0	+0	0	31	58.8%
12/19	NYK	W 116-107	37	30	2	9	0	1	3	12	6	50.0%	12	5	41.7%	24	11	45.8%	2	2	100.0%	0	2	3.0	+7	4	26	60.3%
12/7	LAL	L 112-108	38	28	7	9	2	2	3	8	5	62.5%	16	6	37.5%	24	11	45.8%	2	1	50.0%	0	7	3.0	-9	2	29	56.3%
12/5	MIL	W 116-101	36	12	4	4	1	4	2	3	0	0.0%	11	5	45.5%	14	5	35.7%	2	2	100.0%	2	2	2.0	+16	2	13	40.3%
12/4	GSW	W 99-98	39	35	3	2	1	2	3	10	4	40.0%	17	9	52.9%	27	13	48.1%	5	5	100.0%	0	3	0.7	+7	2	26	59.9%
12/2	WAS	W 121-102	28	35	4	6	1	4	0	9	4	44.4%	17	9	52.9%	26	13	50.0%	5	5	100.0%	0	4	0.0	+23	2	34	62.1%
11/30	ATL	L 142-134	52	44	7	9	1	0	6	13	2	15.4%	18	12	66.7%	31	14	45.2%	17	14	82.4%	0	7	1.5	-8	2	42	57.2%
11/28	BKN	W 115-103	41	22	9	7	1	1	1	8	2	25.0%	8	5	62.5%	16	7	43.8%	6	6	100.0%	0	9	7.0	+8	2	31	59.0%
11/25	ORL	L 144-103	31	20	1	4	0	1	1	5	1	20.0%	10	6	60.0%	15	7	46.7%	6	5	83.3%	0	1	4.0	-30	2	17	56.7%
11/23	MIA	L 127-117	36	27	3	6	0	2	3	14	5	35.7%	9	5	55.6%	23	10	43.5%	2	2	100.0%	0	3	2.0	-14	2	22	56.5%
11/20	MIL	W 123-114	46	54	5	9	3	3	5	15	6	40.0%	15	12	80.0%	30	18	60.0%	14	12	85.7%	0	5	1.8	+18	3	62	74.7%
11/19	TOR	L 121-112	38	24	2	9	1	3	3	9	5	55.6%	5	3	60.0%	14	8	57.1%	4	3	75.0%	1	1	3.0	-2	1	32	76.1%
11/17	LAC	W 110-108	40	39	3	6	0	1	4	11	4	36.4%	16	9	56.3%	27	13	48.1%	10	9	90.0%	0	3	1.5	+4	1	36	62.1%
11/14	DET	L 114-105	39	31	7	3	0	4	3	11	2	18.2%	20	11	55.0%	31	13	41.9%	3	3	100.0%	0	7	1.0	-10	2	22	48.0%
11/11	BOS	W 102-100	33	21	5	9	0	1	0	6	3	50.0%	11	2	18.2%	17	5	29.4%	8	8	100.0%	0	5	0.0	-6	3	24	51.2%
11/9	DET	L 111-108	38	33	4	7	0	2	3	12	4	33.3%	14	6	42.9%	26	10	38.5%	9	9	100.0%	0	4	2.3	-6	3	29	55.1%
11/8	TOR	W 130-120	42	31	4	7	2	1	1	10	3	30.0%	14	9	64.3%	24	12	50.0%	5	4	80.0%	1	3	7.0	+21	3	31	59.2%
11/5	CLE	L 132-121	36	27	7	9	0	1	5	5	2	40.0%	15	8	53.3%	20	10	50.0%	8	5	62.5%	1	6	1.8	-7	2	28	57.4%
11/4	CHI	L 113-111	39	39	5	5	3	1	4	10	6	60.0%	16	8	50.0%	26	14	53.8%	5	5	100.0%	0	5	1.3	+3	2	38	69.1%
11/2	BKN	W 129-105	38	26	6	7	0	1	1	9	4	44.4%	10	5	50.0%	19	9	47.4%	4	4	100.0%	0	6	7.0	+21	3	28	62.6%
10/31	BOS	L 109-108	43	26	8	14	2	2	5	9	4	44.4%	7	4	57.1%	16	8	50.0%	7	6	85.7%	1	7	2.8	+10	2	39	68.1%
10/28	WAS	W 139-134	47	39	3	10	1	1	4	9	3	33.3%	16	8	50.0%	25	11	44.0%	16	14	87.5%	0	3	2.5	+3	3	39	60.9%
10/27	ORL	W 136-124	41	43	4	8	0	1	1	11	4	36.4%	21	11	52.4%	32	15	46.9%	10	9	90.0%	0	4	8.0	+14	1	42	59.1%
10/25	CHA	W 125-121	41	28	6	9	1	0	2	9	4	44.4%	11	3	27.3%	20	7	35.0%	12	10	83.3%	1	5	4.5	+3	3	29	55.4%
10/22	BOS	W 117-116	41	40	2	6	1	2	1	9	7	77.8%	15	6	40.0%	24	13	54.2%	8	7	87.5%	0	2	6.0	+3	5	35	72.7%
Regular Season Totals			38.2	28.4	4.2	6.7	0.8	1.9	2.4	8.6	3.2	36.7%	13.0	6.8	52.3%	21.6	9.9	46.1%	6.0	5.3	89.1%	0.3	3.8	2.8	+100	2.2	31.3	58.6%

Postseason
Date	Opp	Result	MIN	PTS	REB	AST	BLK	STL	TO	3PA	3PM	3P%	2PA	2PM	2P%	FGA	FGM	FG%	FTA	FTM	FT%	OREB	DREB	A/TO	+/-	PF	PER	TS%
4/21	BOS	W 111-97	39	29	4	9	0	2	1	12	5	41.7%	16	6	37.5%	28	11	39.3%	2	2	100.0%	1	3	9.0	+6	2	28	50.2%
4/19	BOS	L 123-91	36	21	1	8	0	0	3	4	1	25.0%	16	7	43.8%	20	8	40.0%	5	4	80.0%	0	1	2.7	-29	4	15	47.3%
Postseason Totals			38.1	25.0	2.5	8.5	0.0	1.0	2.0	8.0	3.0	37.5%	16.0	6.5	40.6%	24.0	9.5	39.6%	3.5	3.0	85.7%	0.5	2.0	4.3	-23	3.0	25.0	48.9%

Tyrese Maxey: Breaking News

Maxey provided 29 points (11-28 FG, 5-12 3Pt, 2-2 FT), four rebounds, nine assists and two steals in 40 minutes during Tuesday's 111-97 victory over Boston in Game 2 of the first round of the Eastern Conference playoffs. Maxey and VJ Edgecombe combined for 59 points as the 76ers leveled this series at one win apiece. While his counting stats have been solid thus far, Maxey is shooting 39.6 percent from the field through two playoff games.

Maxey logged 21 points (8-20 FG, 1-4 3Pt, 4-5 FT), eight assists and one rebound over 37 minutes during the 76ers' 123-91 loss to the Celtics in Game 1 of their Eastern Conference first-round playoff series Sunday. Maxey scored 14 of his team-high 21 points in the first half, though he connected on just five of 14 field-goal attempts in that span. The Sixers' offense struggled in Game 1, with Maxey being the only player on the team to score 20-plus points, and he also got his teammates involved with a game high in assists. He is going to be the engine to the Sixers' offense, especially in the absence of Joel Embiid (appendectomy).

Maxey finished with 31 points (11-25 FG, 3-9 3Pt, 6-8 FT), two rebounds, six assists, one block and one steal over 42 minutes during Wednesday's 109-97 Play-In Game victory over Orlando. Maxey continued his dominant season, scoring a game-high 31 points, lifting the 76ers to an emphatic victory. Despite being without Joel Embiid (appendicitis), Philadelphia was able to get the job done over a disappointing Magic outfit. Although Boston will go into the first-round series as firm favorites, Maxey will certainly be giving it his all in the hopes of causing an upset.